MRI Predictors of Survival in Patients with Glioblastomas
Abstract
Objective: To evaluate predictive value of MRI findings in overall survival of glioblastoma patients.
Methods: A retrospective study was performed in 11 consecutive adult glioblastoma patients who underwent primary surgery, radiation and chemotherapy. The Kaplan-Meier curve was used to estimate overall survival probabilities. Fisher’s exact test or Mann-Whitney U Test was used to explore the association between clinical and imaging factors and 2-year survival.
Results: The median survival for glioblastoma patients in this study was 963 days. Patients with tumor necrosis less than 50%, presence of pre-operative non-enhancing tumor (nCET), perilesional edema less than tumor volume, presence of cystic portion, absence of multifocality, extent of resection more than 50% involving noneloquent location, and the mass effect more than 5 mm had positive trends of longer survival (more than 2 years) implying better prognosis. However, no statistical significance was demonstrated.
Conclusion: MR imaging features were useful predictors for survival in glioblastoma patients.
Keywords: MRI, glioblastoma, survival, predictor
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following conditions:
Copyright Transfer
In submitting a manuscript, the authors acknowledge that the work will become the copyrighted property of Siriraj Medical Journal upon publication.
License
Articles are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). This license allows for the sharing of the work for non-commercial purposes with proper attribution to the authors and the journal. However, it does not permit modifications or the creation of derivative works.
Sharing and Access
Authors are encouraged to share their article on their personal or institutional websites and through other non-commercial platforms. Doing so can increase readership and citations.